Contrive Datum Insights has published "Brain Monitoring Market Size, Share & Industry Analysis, By Product type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Intracranial Pressure (ICP) Monitors, Cerebral Oximeters, Magnetic Resonance Imaging (MRI) Devices, Computerized Tomography (CT) Devices, Positron Emission Tomography (PET) Devices, Sleep Monitoring Devices, Electromyography (EMG) Devices), Accessories (Electrodes, Sensors, Pastes and Gels, Caps, Cables, Batteries, Others), Procedure (Non-invasive, Invasive), Application (Epilepsy, Dementia, Parkinson's Disease, Huntington's Disease, Headache Disorders, Stroke, Traumatic Brain Injuries, Sleep Disorders, Other Diseases), End user (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Home Care Settings, Research & Academic Institutes), and Regional Forecast, 2026-2034". The study sizes the global brain monitoring market at USD 5.4 billion in 2025 and projects growth from USD 5.9 billion in 2026 to USD 11.54 billion by 2034, a compound annual growth rate of 8.75% across the forecast period.
Brain monitoring covers the instruments and disposable accessories used to record, image or measure electrical, metabolic and pressure activity in the brain for diagnosis and ongoing patient management. The category spans electroencephalography and magnetoencephalography systems, transcranial Doppler and cerebral oximetry devices, intracranial pressure monitors, the neuro-specific use of imaging modalities such as MRI, CT and PET, and the electrodes, sensors, caps and gels these systems consume with each use. Buyers range from hospital neurology and intensive care departments to sleep laboratories, diagnostic imaging centers and, increasingly, home-testing services that support long-term patient follow-up.
Rising global burden of neurological and stroke-related disease
Rising global burden of neurological and stroke-related disease is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 8.75% a year, the product type lines exposed to it move fastest: Sleep Monitoring Devices compounds at 12.59%, taking its share of revenue from 10.93% to 14.99% and its value from USD 0.59 billion to USD 1.73 billion.
Where the forecast could be beaten: the bull case assumes home and ambulatory sleep and EEG monitoring displaces in-lab testing faster than expected and that neuroimaging capacity expansion in Asia Pacific and the Middle East proceeds on an accelerated timeline. The study puts that case at USD 13.3 billion in 2034, against USD 11.54 billion in the base.
On the downside, the bear case assumes reimbursement growth for neurodiagnostic procedures slows in major markets and that capital budgets for MRI, CT and EEG replacement cycles are deferred amid broader hospital cost pressure, which would hold 2034 revenue to USD 10.04 billion. Electroencephalography (EEG) Devices, which carries 22.04% of 2025 revenue, already grows at only 8.19% against the market's 8.75%, so the largest part of the base is also its slowest.
Electroencephalography (EEG) Devices Scale Against Sleep Monitoring Devices Momentum
Two positions matter, and they are set by product type. Electroencephalography (EEG) Devices carries 22.04% of 2025 revenue (USD 1.19 billion) and is still the largest line in 2034 at 20.97%, hard to take from an incumbent. Sleep Monitoring Devices, at 12.59%, is where the USD 5.4 billion base is redistributed. The two demand different capabilities.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Accessories | Electrodes | 27.96% · USD 1.51 billion | Batteries 10.31% |
| Procedure | Non-invasive | 82.04% · USD 4.43 billion | — |
| Application | Epilepsy | 19.81% · USD 1.07 billion | Sleep Disorders 10.38% |
| End user | Hospitals | 47.96% · USD 2.59 billion | Home Care Settings 12.19% |
- Regionally, the lead sits with North America: 40% of 2025 global revenue, USD 2.16 billion rising to USD 4.15 billion in 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 23% in 2025 to 28% in 2034, with revenue growing from USD 1.24 billion to USD 3.23 billion.
- At 4.5% of 2025 revenue and 5% by 2034, Middle East and Africa is the smallest region throughout.
- By product type, the largest line in 2025 was Electroencephalography (EEG) Devices, at 22.04% of revenue and USD 1.19 billion.
- Sleep Monitoring Devices is projected to grow at 12.59% over the forecast period, the fastest of any product type line.
- The United States is the largest single country market at USD 1.84 billion in 2025, 34.07% of global revenue.
The study covers five axes, by product type, and by accessories, procedure, application and end user, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 10.04 billion and USD 13.3 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.